Scientific News
Diet shapes probiotic colonization, offering strategies to improve colonization, modulate the microbiota, and control harmful microbes.
Francesco Asnicar, CIBIO - University of Trento (Italy), discusses new large-scale research on the human microbiome, based on the analysis of more than 35,000 individuals from the UK and the…
Monitoring shifts in microbial interaction networks could help to detect and track gut-related conditions.
Bacteria such as Enterococcus faecium and Limosilactobacillus reuteri are key in activating an immune receptor that boosts the activity of protective immune cells.
The longevity industry is measuring everything except what matters most.
Amine Zorgani explains how SwipeBiome moves beyond traditional stool testing toward real-time microbiome prediction based on patient metadata.
Targeting specific bacterial strains, rather than overall gut diversity, can help develop effective microbiota therapies.
In periodontitis, helpful gum bacteria become less active while harmful bacteria change their behavior to feed on available nutrients and worsen disease, suggesting new targeted treatment approaches.
Liam O’Mahony explores how diet influences the immune system through the metabolic activity of the gut microbiota.
Bacterial extracellular vesicles released by L. salivarius activate immune cells, boosting the effectiveness of immunotherapy in stomach cancer.
Uncultured gut bacteria, particularly one group called CAG-170, are key contributors to a healthy microbiota.
Giulia Collattuzzo, University of Bologna, presents study findings showing an independent protective association between dietary fiber and gastric cancer risk, with consistent effects across sex, tumor location, and histological subtype.
Why Formula 1 will build the future of personalised medicine before medicine does.
Bifidobacterium longum and B. infantis are distinct species with strains adapted to local diets, highlighting the importance of developing geographically tailored infant probiotics.
HMGB1 is a key protein that blocks bacterial adhesion and virulence, protecting intestinal cells and helping to maintain a healthy microbiota.
The fifth edition of IBS Days, a congress entirely dedicated to Irritable Bowel Syndrome, will take place in Bologna, Italy, from June 15 to 17, 2026.
Giuseppe Penna, from Humanitas University (Italy), presents the development of a novel postbiotic obtained from a single bacterial strain through an innovative fermentation process.
Giovanni Marasco, University of Bologna, discusses the growing evidence that links gut microbiota dysbiosis to the pathophysiology, clinical prognosis, disease progression, and treatment response of patients with IBD.
Modifying the microbiota through a fecal transplant can be safely combined with immunotherapy in people with kidney cancer.
Restoring R. gnavus or supplementing isovaleric acid could be a promising microbiota–based strategy to prevent or treat atrial fibrillation.
